Sort
10,829 grants matching “car t”
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$734,238Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$734,238Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
NANOPHOTOSENSITIZERS FOR REGENERATIVE PHOTOTHERAPY
$734,204Samuel Achilefu · Ut Southwestern Medical Center · R01 · FY2022 · CA
Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
$734,126Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
(PQA4) GPS exposure to environments & relations with biomarkers of cancer risk
$733,604Jacqueline Kerr · University Of California, San Diego · R01 · FY2013 · CA
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection
$733,555Yi Zhang · Hackensack University Medical Center · R01 · FY2025 · CA
TCR engineered T cell therapies for hematologic malignancies
$733,139Kazusa Ishii · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity
$733,069Hao Wu · Boston Children'S Hospital · R01 · FY2025 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity
$733,069Hao Wu · Boston Children'S Hospital · R01 · FY2024 · CA
Sensor Network with Active Instructional Content to Prevent Child Safety Seat Misuse
$731,928Sara Seifert · Minnesota Healthsolutions Corporation · R44 · FY2021 · HD
Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis
$730,947David Schnadower · Washington University · R01 · FY2016 · HD
Building the foundations of commensal vaccines
$730,870Michael Andrew Fischbach · Stanford University · R01 · FY2025 · AI
Closed-Loop Effectiveness and Ambulatory Regimens (CLEAR)
$730,792Stuart A Weinzimer · Yale University · R01 · FY2010 · DK
Cellular Immunotherapy for Systemic Sclerosis
$730,718Joana M Murad · Celdara Medical, Llc · R44 · FY2020 · AR
Impact of Emergency Department Probiotic Treatment of Pediatric Gastroenteritis
$730,694David Schnadower · Washington University · R01 · FY2017 · HD
NexTGen - STANFORD
$730,473Irving Lerner Weissman · Stanford University · OT2 · FY2022 · CA
In Vivo Gene Editing of B cells with NICE-AAV Vectors
$730,441Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation
$730,398Jonathan B Bricker · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation
$730,398Jonathan B Bricker · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Clinical production of viral vectors for cancer gene therapy
$730,187Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care
$730,012Nancy L Keating · Harvard Medical School · R01 · FY2021 · CA
Montana Cancer Consortium NCORP
$730,000Benjamin T. Marchello · Montana Cancer Consortium · UG1 · FY2014 · CA
Unified Intervention to Impact HIV Care Continuum
$729,750Seth C Kalichman · University Of Connecticut Storrs · R01 · FY2016 · DA
MUC16 Antibody Based Strategies for Imaging and Therapy
$729,636David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2018 · CA
MUC16 Antibody Based Strategies for Imaging and Therapy
$729,636David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA